Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Residual Oxygen Testing by GC – V 2.0

Posted on By

Analytical Method Development: SOP for Residual Oxygen Testing by GC – V 2.0

Standard Operating Procedure for Residual Oxygen Testing Using Gas Chromatography


Department Analytical Method Development
SOP No. SOP/AMD/183/2025
Supersedes SOP/AMD/183/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP establishes a validated analytical procedure for determining residual oxygen content in pharmaceutical container headspace using Gas Chromatography (GC) equipped with a Thermal Conductivity Detector (TCD) or Barrier Discharge Ionization Detector (BID). This

test ensures the effectiveness of nitrogen purging, container closure integrity, and product stability.

2. Scope

This procedure applies to ampoules, vials, and pre-filled syringes filled with sterile injectables or lyophilized products packaged under nitrogen atmosphere, and is intended for use in development, validation, and quality control testing.

3. Responsibilities

  • Analytical Scientist: Develops and validates the GC method for oxygen detection.
  • QC Analyst: Prepares standards, samples, and runs GC analysis as per protocol.
  • QA Officer: Ensures the reviewed results meet acceptance criteria and regulatory expectations.
  • Head – AMD: Approves the method and oversees its implementation in GMP settings.
See also  Analytical Method Development: SOP for Compatibility Testing of Actives with Diluent - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the residual oxygen test method meets analytical performance standards and supports product shelf-life claims.

5. Procedure

5.1 Instrument and Detector Configuration

  1. Use GC system equipped with:
    • Thermal Conductivity Detector (TCD) or Barrier Discharge Ionization Detector (BID)
    • Molecular sieve column (e.g., 5Å or porous polymer column)
    • Headspace autosampler (preferred)
  2. Carrier gas: Helium or Nitrogen
  3. Column temp: 40°C isothermal; Injector: 150°C; Detector: 200°C
  4. Record baseline and calibration in Annexure-1: GC Calibration Log

5.2 Standard Preparation

  1. Use certified calibration gas mixtures containing 1%, 5%, 10% oxygen in nitrogen.
  2. Transfer known volumes into headspace vials and seal immediately with crimp caps.
  3. Ensure gas-tight sealing and consistent vial volumes across standards and test samples.

5.3 Sample Handling and Testing

  1. Transfer sample containers from cold storage to room temperature (25 ± 2°C).
  2. Wipe each container to remove surface contaminants.
  3. Puncture the rubber closure using automated headspace sampling needle or manual gastight syringe.
  4. Inject fixed headspace volume (e.g., 1 mL) into GC system.
  5. Perform blank and standard runs before each batch.
  6. Calculate oxygen % in headspace using calibration curve.
  7. Log all results in Annexure-2: Residual Oxygen Report.
See also  Analytical Method Development: SOP for Disintegration Time Testing Method Development - V 2.0

5.4 Method Validation

  1. Validate as per ICH Q2(R2) and USP <1207> guidelines:
    • Linearity: 1% to 20% oxygen (R² ≥ 0.995)
    • LOD/LOQ: Detect and quantify levels down to 0.5% if applicable
    • Precision: RSD ≤ 3% at 5% oxygen
    • Accuracy: Recovery 95%–105%
    • Robustness: Assess at different vial sizes and needle depths
  2. Summarize validation in Annexure-3: GC Validation Summary

5.5 Acceptance Criteria

  1. Residual oxygen ≤ 1.0% (for nitrogen-filled containers unless otherwise justified)
  2. No leakage or compromised closure integrity
  3. Consistent results across replicate containers (n = 3 minimum)

6. Abbreviations

  • GC: Gas Chromatography
  • TCD: Thermal Conductivity Detector
  • BID: Barrier Discharge Ionization Detector
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SOP: Standard Operating Procedure

7. Documents

  1. GC Calibration Log – Annexure-1
  2. Residual Oxygen Report – Annexure-2
  3. GC Validation Summary – Annexure-3

8. References

  • USP <1207> – Package Integrity Evaluation
  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance – Container Closure Systems for Packaging Human Drugs
  • European Pharmacopoeia – Residual Oxygen Test

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: GC Calibration Log

Date Std. Gas (% O₂) Response (Area) R² Value Analyst
18/05/2025 5.0% 18276 0.9986 Rajesh Kumar

Annexure-2: Residual Oxygen Report

Container ID Sample Type O₂ Content (%) Acceptance Limit (%) Status
VIAL-245 Lyophilized 0.8 ≤1.0 Complies

Annexure-3: GC Validation Summary

Parameter Result Criteria Status
Precision RSD = 2.1% ≤ 3% Pass
Accuracy 96.3% 95–105% Pass
LOD 0.3% ≤ 0.5% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated calibration gases and detection parameters Regulatory audit readiness
See also  Analytical Method Development: SOP for Qualification and Performance Verification of Analytical Balances - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Calibration of Temperature Probes – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Handling and Storage of Packaging Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version